USFDA makes 'certain' observations for Torrent Pharma's Indrad plant

USFDA has madecertain observations about Torrent Pharma Indrad plant in Gujarat. It has issued FDA Form 483 to the firm. It notifies the firm of objectionable conditions. The company has said to comply with their regulation process. The firm hasn't quantified the number of observations by them.

Disclaimer : Mytimesnow (MTN) lets you explore worldwide viral news just by analyzing social media trends. Tap read more at source for full news. The inclusion of any links does not necessarily imply any endorsement of the views expressed within them.